Biotech Law 
Plan would grow marijuana in former Mich. mine – Mining Journal
(AP) — A Canadian biotechnology company wants to cultivate medical marijuana … Michigan voters approved the use of medical marijuana in 2008, but the law does not explain where people are supposed to get marijuana if they don’t grow it … Continue reading
Voter ID law gets dry run Tuesday – Scranton Times-Tribune
The controversial voter ID law is probably the biggest change voters will notice … defense plant executive David Christian, lawyer Marc Scaringi, biotech valve inventor Steven Welch, former coal company owner and farmer Tom Smith and former …
PROLOR Biotech, Inc. : PROLOR Biotech Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders – 4-traders (press release)
The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. 04/17 PROLOR Biotech …
Human Genome Sciences rejects $2.59B GlaxoSmithKline bid – The Business Journal
as well as the law firms Skadden, Arps, Slate, Meagher & Flom LLP and DLA Piper LLP. GSK has been invited to participate in those talks, the Maryland biotech said. HGS expects to be mum on the process: “There can … Continue reading
Advances in shaking technologies
Wolf Klöckner, Jochen Büchs. Shaking bioreactors are the most frequently used reactor system for screening and process optimization on a small scale. Their success can be attributed to their simple and functional design, whic….
Human Genome Sciences Rejects $2.59 Billion Offer From GlaxoSmithKline – New York Times
LONDON – The biotechnology company Human Genome Sciences rejected … Human Genome Sciences has retained Goldman Sachs, Credit Suisse, and the law firms Skadden, Arps, Slate, Meagher & Flom and DLA Piper to help with its potential sale.
O’Melveny Adds Stanton Lovenworth to Health Care and Life Sciences Practice – pressreleasepoint.com
“With more than three decades of experience representing leading companies in intellectual property transactions, particularly in the pharmaceutical and biotechnology sectors … received a J.D. from Columbia Law School, where he was a Harlan Fiske …
Biotech Co. Human Genome Rejects $2.6B Bid From GSK – site.law360.com
Law360, New York (April 19, 2012, 1:24 PM ET) — Gene-targeting drug developer Human Genome Sciences Inc. on Thursday rejected an unsolicited $2.59 billion bid from GlaxoSmithKline PLC, but a cozy relationship between the companies could still result in a … Continue reading
Human Genome Sciences (Nasdaq: HGSI) Soars on Takeover Bid – Emailwire
Shawshank, VA 4/19/12 (StreetBeat) — The biotechnology company Human Genome Sciences (Nasdaq … Human Genome Sciences has retained Goldman Sachs, Credit Suisse, and the law firms Skadden, Arps, Slate, Meagher & Flom and DLA Piper to help with its …
Distributed computation: the new wave of synthetic biology devices
Javier Macía, Francesc Posas, Ricard V. Solé. Synthetic biology (SB) offers a unique opportunity for designing complex molecular circuits able to perform predefined functions. But the goal of achieving a flexible toolbox of reusable molecular….
